Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction

NCT04340180 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT04340180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04340180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 1
Overall status
Completed
Start date
July 14, 2021
Completion date
January 20, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast benign tumor, breast malignant tumor